| 08:30 - 10:30 | 150 | Respiratory Infections Grand Round – an interactive session | Grand round |
| 08:30 - 10:30 | 151 | Pulmonary alveolar proteinosis: clearing the Milky Way | Symposium |
| 08:30 - 10:30 | 152 | What is the best screening method for obstructive sleep apnoea/hypopnoea syndrome? | Symposium |
| 08:30 - 10:30 | 153 | Fitness for radical therapy in lung cancer patients | Symposium |
| 08:30 - 10:30 | 154 | "Getting dark, too dark to see": end-of-life care in patients with chronic respiratory diseases | Symposium |
| 08:30 - 10:30 | 155 | Pathobiology of pulmonary hypertension | Oral Presentation |
| 08:30 - 10:30 | 156 | Allergic rhinitis and its impact on asthma in children | Symposium |
| 08:30 - 10:30 | 157 | Pathology and immunology of COPD | Oral Presentation |
| 08:30 - 10:30 | 158 | Infections, immunity and inflammation | Oral Presentation |
| 08:30 - 10:30 | 159 | Exciting studies with old and new lung function tests | Oral Presentation |
| 08:30 - 10:30 | 160 | Cystic fibrosis: disease progression and novel therapies | Oral Presentation |
| 08:30 - 10:30 | 161 | Treatment of COPD | Oral Presentation |
| 08:30 - 10:30 | 162 | Passive smoking | Oral Presentation |
| 08:30 - 10:30 | 163 | Clinical advances in childhood asthma | E-Communication Session |
| 08:30 - 10:30 | 164 | Preoperative functional assessment and surgery for malignant diseases | E-Communication Session |
| 08:30 - 10:30 | 165 | From bench to bedside: diagnosis of tuberculosis | E-Communication Session |
| 08:30 - 10:30 | 166 | New treatment and outcome measures for pulmonary rehabilitation | E-Communication Session |
| 08:30 - 10:30 | 167 | Respiratory mechanics, tissue and cell dysfunction in pulmonary disease | E-Communication Session |
| 08:30 - 10:30 | 168 | Indoor and outdoor air pollution | E-Communication Session |
| 10:45 - 12:45 | 169 | Occupational Grand Round: "Idiosyncratic interstitial lung diseases which are caused by work" - an interactive session | Grand round |
| 10:45 - 12:45 | 170 | The influenza A (H1N1) pandemic | Hot topics |
| 10:45 - 12:45 | 171 | Pressure for plasticity: the pulmonary interstitium in the diseased lung | Symposium |
| 10:45 - 12:45 | 172 | Central sleep apnoea: new challenges, new opportunities | Symposium |
| 10:45 - 12:45 | 173 | COPD, chronic respiratory failure and rehabilitation | Symposium |
| 10:45 - 12:45 | 174 | Impact of biomarkers in the management of community-acquired pneumonia | Oral Presentation |
| 10:45 - 12:45 | 175 | Early life origins of asthma and atopy: is epigenetics the key? | Hot topics |
| 10:45 - 12:45 | 176 | New insights in biology and treatment of pleural tumours | Oral Presentation |
| 10:45 - 12:45 | 177 | New drugs for airways disease | Oral Presentation |
| 10:45 - 12:45 | 178 | Acute lung injury: biological mechanisms | Oral Presentation |
| 10:45 - 12:45 | 179 | Diagnostic and interventional bronchoscopy in children | Oral Presentation |
| 10:45 - 12:45 | 180 | Treatment beyond inhalers | Oral Presentation |
| 10:45 - 12:45 | 181 | COPD case-finding and management in primary care | Oral Presentation |
| 10:45 - 12:45 | 182 | Quality control in lung function and new developments | E-Communication Session |
| 10:45 - 12:45 | 183 | Severe asthma and its treatment | E-Communication Session |
| 10:45 - 12:45 | 184 | Pulmonary circulation | E-Communication Session |
| 10:45 - 12:45 | 185 | Epidemiology of asthma | E-Communication Session |
| 10:45 - 12:45 | 186 | Diagnosis of pleural effusions and rare tumours experience | E-Communication Session |
| 10:45 - 12:45 | 187 | Pulmonary embolism and cardiovascular diseases | E-Communication Session |
| 13:00 - 14:00 | 188 | Meet the Risk Communication Experts: "Fundamentals of risk communication: How to talk to patients and the public about pandemic H1N1" | Symposium |
| 12:50 - 14:40 | 189 | Aspects of clinical asthma | Thematic Poster Session |
| 12:50 - 14:40 | 190 | Aspects of uncontrolled asthma | Thematic Poster Session |
| 12:50 - 14:40 | 191 | Drug effects in COPD | Thematic Poster Session |
| 12:50 - 14:40 | 192 | New bronchodilators | Thematic Poster Session |
| 12:50 - 14:40 | 193 | New aspects of inhalation therapy | Thematic Poster Session |
| 12:50 - 14:40 | 194 | Models of chronic airways disease and therapy | Thematic Poster Session |
| 12:50 - 14:40 | 195 | Treatment of airways disease | Thematic Poster Session |
| 12:50 - 14:40 | 196 | Animal models of airways inflammation | Thematic Poster Session |
| 12:50 - 14:40 | 197 | Inflammation and airways | Thematic Poster Session |
| 12:50 - 14:40 | 198 | Inflammatory cells and cytokines | Thematic Poster Session |
| 12:50 - 14:40 | 199 | Clinical aspects of inflammatory airways diseases | Thematic Poster Session |
| 12:50 - 14:40 | 200 | Pleural problems, congenital lesions and novel technical devices | Thematic Poster Session |
| 12:50 - 14:40 | 201 | Lung infections; diagnostic and therapeutic problems | Thematic Poster Session |
| 12:50 - 14:40 | 202 | Operative technique, postoperative complications; rare pathology | Thematic Poster Session |
| 12:50 - 14:40 | 203 | Human and experimental lung transplantation: novel findings | Thematic Poster Session |
| 12:50 - 14:40 | 204 | Accuracy in lung function testing | Thematic Poster Session |
| 12:50 - 14:40 | 205 | Respiratory physiotherapy assessment | Thematic Poster Session |
| 12:50 - 14:40 | 206 | Treatment modalities in chest physiotherapy | Thematic Poster Session |
| 12:50 - 14:40 | 207 | Physiotherapy aspects in cystic fibrosis and functional assessment | Thematic Poster Session |
| 12:50 - 14:40 | 208 | Nursing challenges at home and in hospital | Thematic Poster Session |
| 12:50 - 14:40 | 209 | Exacerbations of COPD and bronchiectasis: aetiology and treatment | Thematic Poster Session |
| 12:50 - 14:40 | 210 | Assessment of severity in respiratory infections: severity scales and biomarkers | Thematic Poster Session |
| 12:50 - 14:40 | 211 | Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia | Thematic Poster Session |
| 12:50 - 14:40 | 212 | Aetiology and diagnosis of lower respiratory tract infections | Thematic Poster Session |
| 12:50 - 14:40 | 213 | Treatment and prevention of lower respiratory tract infections | Thematic Poster Session |
| 12:50 - 14:40 | 214 | Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus | Thematic Poster Session |
| 12:50 - 14:40 | 215 | Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections | Thematic Poster Session |
| 12:50 - 14:40 | 216 | Tuberculosis at different age groups | Thematic Poster Session |
| 12:50 - 14:40 | 217 | Socio-economic impact of tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 218 | Diagnostic advances in tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 219 | Tuberculosis: metabolism and comorbidities | Thematic Poster Session |
| 12:50 - 14:40 | 220 | Clinical immunology of tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 221 | Clinical tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 222 | Tuberculosis control | Thematic Poster Session |
| 12:50 - 14:40 | 223 | Management of thoracic malignancies | Thematic Poster Session |
| 12:50 - 14:40 | 224 | Treatment of lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 225 | Biological and clinical markers in lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 226 | Clinical aspects and epidemiology in lung cancer | Thematic Poster Session |
| 12:50 - 14:40 | 227 | Various diagnostic aspects in lung cancer and rare lung tumours | Thematic Poster Session |
| 13:00 - 14:30 | 228 | LANCET/ERS symposium: “Evolving dimensions of COPD” | Symposium |
| 13:00 - 14:30 | 229 | Medicine in Vienna | Symposium |
| 13:00 - 14:00 | 230 | EU Research Programmes. IMI: 1. U-BIOPRED asthma 2. PROactive COPD | Symposium |
| 13:00 - 14:30 | 231 | Lunchtime Programme "ERS Fellows' lunch" | Symposium |
| 13:00 - 14:00 | 238 | MP7 - Targeting airway inflammation in asthma: current and future therapies | Meet the Professor |
| 13:00 - 14:00 | 239 | MP8 - Noninvasive assessment in the evaluation of occupational lung diseases | Meet the Professor |
| 13:00 - 14:00 | 241 | MP10 - Multidisciplinary mesothelioma treatment: practical aspects including palliative care | Meet the Professor |
| 13:00 - 14:00 | 242 | MP11 - Healthcare-associated pneumonia: a new challenge | Meet the Professor |
| 15:05 - 16:45 | 244 | Clinical Grand Round - an interactive session | Grand round |
| 14:45 - 15:05 | 245 | COPD Award (supported by Boehringer Ingelheim) | Session |
| 15:05 - 16:45 | 246 | Paediatric year in review | Hot topics |
| 14:45 - 15:05 | 247 | Lifetime Achievement Award (supported by Merck & Co., Inc.) | Session |
| 14:45 - 16:45 | 248 | Evidence-based tobacco control in Europe | Symposium |
| 14:45 - 16:45 | 249 | Antibiotics and the lung | Symposium |
| 14:45 - 16:45 | 250 | The lung cancer-COPD nexus | Symposium |
| 14:45 - 16:45 | 251 | Acute and chronic venous thromboembolic disease | Oral Presentation |
| 14:45 - 16:45 | 252 | Home ventilation services: the patient on home ventilation | Symposium |
| 14:45 - 16:45 | 253 | Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide | Symposium |
| 14:45 - 16:45 | 254 | Hot topics in molecular pathology and functional genomics of COPD | Oral Presentation |
| 14:45 - 16:45 | 255 | Severe sepsis and multiple organ failure | Oral Presentation |
| 14:45 - 16:45 | 256 | Risk factors for asthma and pneumonia | Oral Presentation |
| 14:45 - 16:45 | 257 | Asthma genetics: from genome wide to single nucleotide polymorphisms | Oral Presentation |
| 14:45 - 16:45 | 258 | Idiopathic pulmonary fibrosis: concepts and mechanisms | Oral Presentation |
| 14:45 - 16:45 | 259 | Systemic consequences of sleep-disordered breathing | E-Communication Session |
| 14:45 - 16:45 | 260 | Cell biology of lung disease | E-Communication Session |
| 14:45 - 16:45 | 261 | Assessment of functional status | E-Communication Session |
| 14:45 - 16:45 | 262 | Imaging of COPD, asthma and emphysema in evolution | E-Communication Session |
| 14:45 - 16:45 | 263 | Trends in bronchoscopy | E-Communication Session |
| 14:45 - 16:45 | 264 | Translational research/biomarkers | E-Communication Session |